Canada Implements New Recall/Disclosure Policy

This article was originally published in The Pink Sheet Daily

06 Aug 2015
News

Neena Brizmohun @ScripRegNeena neena.brizmohun@informa.com

Executive Summary

Health Canada finalizes guideline on its new powers to order recalls or disclose information related to serious risks of injuries for drugs, but says it will develop more details on how it will use the authorities.

Already Registered? Sign in to continue reading.

New to Pink Sheet? Start a free trial today!

Table
View full table

Topics

Canada

ASK THE ANALYST
Email

Print
Bookmark
Share

Tags:

BioPharmaceutical Canada Post Market Regulation & Studies

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

PS078883

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

PS078883

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.

Canada Implements New Recall/Disclosure Policy

News

Executive Summary

Related Content

U.K. Use Of J&J's Cisapride Halted Pending 2001 Ruling On Status In EU

Topics

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Register

Ask The Analyst

Email Article

Sign In To Set a Search Alert